|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1996-10-11
|
|
pubmed:abstractText |
A sustained biochemical and virologic response to standard interferon therapy for chronic hepatitis C is seen in no more than 25% of patients, and the efficacy of re-treatment or of higher doses in non-responders and relapsers has not been established. A more effective therapy for interferon alfa-resistant hepatitis C is needed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-5; discussion 15-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8720288-Antiviral Agents,
pubmed-meshheading:8720288-Aspartate Aminotransferases,
pubmed-meshheading:8720288-Drug Therapy, Combination,
pubmed-meshheading:8720288-Female,
pubmed-meshheading:8720288-Hepacivirus,
pubmed-meshheading:8720288-Hepatitis C,
pubmed-meshheading:8720288-Humans,
pubmed-meshheading:8720288-Interferon Type I,
pubmed-meshheading:8720288-Italy,
pubmed-meshheading:8720288-Liver,
pubmed-meshheading:8720288-Male,
pubmed-meshheading:8720288-Polymerase Chain Reaction,
pubmed-meshheading:8720288-RNA, Viral,
pubmed-meshheading:8720288-Recombinant Proteins,
pubmed-meshheading:8720288-Recurrence,
pubmed-meshheading:8720288-Reference Values,
pubmed-meshheading:8720288-Ribavirin
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
|
|
pubmed:affiliation |
Istituto di Clinica Medica e Gastroenterologia, University of Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
